SecSonar.com

Phibro Animal Health Corporation (PAHC)

Phibro Animal Health Corporation at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Phibro Animal Health Corporation (PAHC) is a Drug Manufacturers - Specialty & Generic company based in US with a market capitalization of $1.3B. Revenue grew 27.4% year-over-year and the company generated $41.8M in free cash flow. This page tracks PAHC's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 1.94K employees · IPO Apr 11, 2014

Valuation

Valuation & price

$34.37 · as of May 17, 2026 · -42.3% vs 52w high

29.0

P/E ratio

Latest-FY diluted EPS

4.43

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$59.58$43.03$26.49Jul 25Dec 25Jul 26Jul 7, 25$29.90Jul 9, 25$31.39Jul 11, 25$30.80Jul 15, 25$30.56Jul 17, 25$29.73Jul 21, 25$29.14Jul 23, 25$29.79Jul 25, 25$29.18Jul 29, 25$28.01Jul 31, 25$26.50Aug 4, 25$27.14Aug 6, 25$26.49Aug 11, 25$28.55Aug 13, 25$30.96Aug 15, 25$30.67Aug 19, 25$31.85Aug 21, 25$31.55Aug 25, 25$31.94Aug 27, 25$32.20Aug 29, 25$37.07Sep 3, 25$38.20Sep 5, 25$39.45Sep 9, 25$41.23Sep 11, 25$41.19Sep 16, 25$39.01Sep 18, 25$40.54Sep 22, 25$38.40Sep 24, 25$38.25Sep 26, 25$38.81Sep 30, 25$40.46Oct 2, 25$39.01Oct 6, 25$37.79Oct 8, 25$37.11Oct 10, 25$36.39Oct 14, 25$37.64Oct 16, 25$38.57Oct 21, 25$41.45Oct 23, 25$41.05Oct 27, 25$41.70Oct 29, 25$41.19Oct 31, 25$42.06Nov 4, 25$42.11Nov 6, 25$43.04Nov 10, 25$45.83Nov 12, 25$45.32Nov 14, 25$45.10Nov 18, 25$43.38Nov 20, 25$40.81Nov 25, 25$44.33Nov 28, 25$41.88Dec 2, 25$40.68Dec 4, 25$40.77Dec 8, 25$40.08Dec 10, 25$39.87Dec 12, 25$40.15Dec 16, 25$40.40Dec 18, 25$40.41Dec 22, 25$37.83Dec 24, 25$37.74Dec 29, 25$37.73Jan 2, 26$37.30Jan 6, 26$39.54Jan 8, 26$39.72Jan 12, 26$39.83Jan 14, 26$39.87Jan 16, 26$41.07Jan 21, 26$41.95Jan 23, 26$39.01Jan 27, 26$39.52Jan 29, 26$39.89Feb 2, 26$41.91Feb 4, 26$41.00Feb 9, 26$51.85Feb 11, 26$51.52Feb 13, 26$52.26Feb 18, 26$51.08Feb 20, 26$52.80Feb 24, 26$51.46Feb 26, 26$54.70Mar 2, 26$54.54Mar 4, 26$51.89Mar 6, 26$47.92Mar 10, 26$50.43Mar 12, 26$49.00Mar 17, 26$52.51Mar 19, 26$52.38Mar 23, 26$53.80Mar 25, 26$57.01Mar 27, 26$53.88Mar 31, 26$55.31Apr 2, 26$55.52Apr 7, 26$55.66Apr 9, 26$59.09Apr 13, 26$59.58Apr 15, 26$55.01Apr 17, 26$57.07Apr 22, 26$53.97Apr 24, 26$55.16Apr 28, 26$54.29Apr 30, 26$53.18May 4, 26$54.68May 6, 26$58.50May 8, 26$40.00May 12, 26$36.58May 14, 26$36.15May 18, 26$34.18May 20, 26$33.81May 22, 26$33.26May 28, 26$31.83Jun 1, 26$29.87Jun 3, 26$31.79Jun 5, 26$32.43Jun 9, 26$32.65Jun 11, 26$31.26Jun 15, 26$32.28Jun 17, 26$30.84Jun 22, 26$31.07Jun 24, 26$31.36Jun 26, 26$31.69Jul 2, 26$33.26
$26.1152-week range$59.58
Loading valuation history…

Fundamentals

Key fundamentals

$1.3B

Market cap

27.4%

Revenue growth (YoY)

30.9%

Gross margin

$41.8M

Free cash flow (USD)

$684.5M

Net debt

-0.0%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$751.5MFY 2017$764.3MFY 2018$820.0MFY 2019$828.0MFY 2020$800.4MFY 2021$833.4MFY 2022$942.3MFY 2023$977.9MFY 2024$1.0BFY 2025$1.3B
$751.5M$1.3B

Free cash flow by year

2016 → 2025

FY 2016$866.0KFY 2017$77.5MFY 2018$51.5MFY 2019$17.3MFY 2020$25.3MFY 2021$19.0MFY 2022$-5.4MFY 2023$-38.5MFY 2024$46.4MFY 2025$41.8M
$866K$41.8M

Gross margin by year

2021 → 2025

FY 202132.6%FY 202230.3%FY 202330.5%FY 202430.8%FY 202530.9%
32.6%30.9%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 6, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventCEO AppointmentJun 26, 2026Filing
  • Quarterly report10-Q FiledMay 6, 2026Filing
  • 8-K eventEarnings ReleaseMay 6, 2026Filing
  • 8-K eventDividend DeclaredMay 5, 2026Filing
  • 8-K eventDebt RefinancingApr 30, 2026Filing
  • 8-K eventRegulatory Change in BrazilApr 27, 2026Filing
  • 8-K eventDirector ResignationApr 14, 2026Filing

Questions

Frequently asked questions

What is Phibro Animal Health Corporation's market cap?

Phibro Animal Health Corporation (PAHC) has a market capitalization of $1.3B.

What is PAHC's P/E ratio?

PAHC trades at a price-to-earnings ratio of 29.0, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is PAHC's price-to-book (P/B) ratio?

PAHC trades at 4.43 times book value per share.

Are insiders buying PAHC stock?

SEC Form 4 filings show no open-market insider buys at Phibro Animal Health Corporation in the last 90 days (0 sells).

Same arena

Related companies in Drug Manufacturers - Specialty & Generic

HROW

Harrow Health, Inc.

$1.3B

EVO

Evotec SE

$1.1B

COLL

Collegium Pharmaceutical, Inc.

$1.1B

ALVO

Alvotech

$1.1B

CRON

Cronos Group Inc.

$1.1B

PRGO

Perrigo Company plc

$1.6B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.